Financial Performance of Blau Farmacêutica, Estapar, and InterCement in Q4 2024

Blau Farmacêutica, one of Brazil’s leading pharmaceutical companies, reported exceptional financial results for the fourth quarter of 2024, with profits more than doubling to R$57 million ($10 million), representing a 102% increase compared to the same period in 2023.

This impressive performance was driven by significant revenue growth, with net revenue reaching R$456 million ($80 million) in Q4, an 18% year-over-year increase. The company achieved record annual revenue of R$1.75 billion ($307 million) for the full year 2024, marking a 28% increase from 2023.

This strong performance aligns with analyst projections, as financial forecasts had indicated growing momentum through 2025, with expected net sales of R$1.96 billion ($344 million) and net income of R$286 million ($50 million) for 2025.

Blau’s hospital segment, which represents its core business, generated revenue of R$363 million ($64 million) in Q4 2024, a 14.9% increase year-over-year.

Meanwhile, its diversified business division—encompassing retail, aesthetics, and plasma products—demonstrated even stronger growth of 30.1%, reaching R$93 million ($16 million).

The company’s EBITDA for Q4 2024 reached R$117 million ($21 million), representing a remarkable 124.4% increase from the previous year, while the annual EBITDA grew by 3.3% to R$381 million ($67 million).

The EBITDA margin expanded significantly to 25.6% in Q4, gaining 12.2 percentage points compared to the same period in 2023. This performance exceeds analyst forecasts, which had projected a 2024 EBITDA margin of 21.34%.

According to Marcelo Hahn, Blau’s CEO, the company is strategically balancing new product development with production capacity expansion, which “is still not at the ideal level”.

The impressive financial results reflect increased production volume, more competitive costs through better procurement of raw materials, improved factory productivity, and the beginning of synergies with Bergamo, a recent acquisition.

Blau maintained a strong financial position with minimal leverage, as its net debt to EBITDA ratio stood at just 0.1x at the end of 2024. This solid financial foundation positions the company for continued expansion in the Brazilian pharmaceutical market, where it has consistently outperformed the industry average growth rate.

Estapar: Narrowing Losses and Expanding Operations

Estapar, Brazil’s largest parking management company, reported significantly reduced losses in Q4 2024, with a net loss of R$3.0 million ($526 thousand), representing a 65.9% decrease compared to the R$8.8 million ($2 million) loss in Q4 2023.

For the full year 2024, the company narrowed its losses to R$8.7 million ($2 million), an impressive 87.2% reduction from the R$68.0 million ($12 million) loss recorded in 2023.

The company’s financial improvement was driven by robust revenue growth, with Q4 2024 net revenue reaching R$430.5 million ($76 million), a 17.8% increase from the previous year.

The full-year revenue totaled R$1.58 billion ($277 million) in 2024, rising 16.8% from R$1.35 billion ($237 million) in 2023. Estapar’s operational expansion has been remarkable, adding approximately 30,000 parking spaces since 2023.

By the end of Q3 2024, the company operated 731 facilities across 96 cities in 18 Brazilian states, compared to 697 operations in 93 cities at the end of 2023. The Q4 2024 period saw further expansion, continuing the company’s strategic growth trajectory.

A significant driver of Estapar’s growth has been its successful digital transformation. The company’s digital platform, including the Zul+ app and Zona Azul de São Paulo app, contributed 19.5% to total revenue in Q4 2024.

The Zul+ app has shown impressive growth, with revenue increasing by 70.0% compared to Q3 2023, attracting over 1.7 million monthly active users.

The company’s EBITDA in Q4 2024 reached R$113.0 million ($20 million), up 7.1% from R$105.5 million ($19 million) in the previous year. For the full year 2024, EBITDA totaled R$455.6 million ($80 million), a 12.1% increase from R$406.4 million ($71 million) in 2023.

Estapar has also ventured into the electric vehicle charging market through its investee company Zletric, which recorded a 69.8% revenue increase compared to Q3 2023. Zletric operates the largest charging network in Brazil, with over 700 stations across 51 cities in 14 states.

The company’s improved financial performance and expanded operations, coupled with its low churn rate of 0.09% (a decrease of 0.17 percentage points), indicate strong customer retention and operational efficiency, positioning Estapar for potential profitability in the near future.

InterCement: Reducing Losses Despite Market Challenges

InterCement Brasil, a major cement manufacturer currently undergoing judicial recovery (bankruptcy protection), showed signs of financial improvement in Q4 2024 despite ongoing challenges. The company reported a net loss of R$120 million ($21 million) for the quarter, a 35% reduction compared to the R$186 million ($33 million) loss in Q4 2023.

For the full year 2024, InterCement narrowed its losses to R$289 million ($51 million), representing a 27% decrease from the R$394 million ($69 million) loss recorded in 2023. This improvement came despite a challenging operating environment, particularly in Argentina, where economic turbulence significantly impacted operations in early 2024.

The company’s Q4 2024 net revenue reached R$830 million ($146 million), a modest 1% increase from R$821 million ($144 million) in the same period of 2023. However, annual revenue for 2024 declined by 7% to R$3.2 billion ($561 million), down from R$3.5 billion ($614 million) in 2023, reflecting persistent market challenges in the cement industry.

EBITDA performance showed improvement, with Q4 2024 EBITDA reaching R$194 million ($34 million), up 2% from R$190 million ($33 million) in the previous year. More significantly, the full-year EBITDA for 2024 increased by a substantial 17% to R$791 million ($139 million), compared to R$676 million ($119 million) in 2023.

InterCement’s financial restructuring efforts continue as the company navigates its judicial recovery process. The company is in talks with potential buyers, including Votorantim (Brazil’s largest cement producer), to sell some of its assets to help reduce its substantial debt burden, which stood at $1.5 billion as of September 2023.

The cement manufacturer operates 23 cement plants, 15 concrete plants, and two aggregates plants across Brazil and Argentina. Despite the challenging market conditions in the cement industry, characterized by lower demand, stronger competition, and higher raw material costs, InterCement’s improved EBITDA performance suggests that operational efficiency measures are beginning to yield results as the company works toward financial stabilization.

Founded in 1967, InterCement has been a significant player in the global cement industry, with previous operations spanning multiple continents including Africa, where it recently sold assets in Mozambique, South Africa, and Egypt as part of its debt reduction strategy.

LatAm Markets: Live Signals → — real-time movers, turnover leaders and FX across Latin America.